Galli, Elena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.465
AS - Asia 2.126
EU - Europa 1.283
SA - Sud America 373
AF - Africa 44
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.309
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.410
SG - Singapore 697
CN - Cina 588
IT - Italia 471
BR - Brasile 285
HK - Hong Kong 273
VN - Vietnam 261
GB - Regno Unito 167
SE - Svezia 122
FI - Finlandia 104
RU - Federazione Russa 97
KR - Corea 83
DE - Germania 80
FR - Francia 65
ID - Indonesia 38
AR - Argentina 37
NL - Olanda 34
AT - Austria 27
BD - Bangladesh 27
JP - Giappone 25
MX - Messico 25
IN - India 22
IQ - Iraq 20
TR - Turchia 20
BG - Bulgaria 19
CA - Canada 18
PL - Polonia 18
AU - Australia 17
MA - Marocco 17
EC - Ecuador 14
LT - Lituania 12
PK - Pakistan 12
CL - Cile 11
AE - Emirati Arabi Uniti 10
ES - Italia 10
ZA - Sudafrica 9
IE - Irlanda 8
PT - Portogallo 8
CO - Colombia 7
EG - Egitto 6
HU - Ungheria 6
KG - Kirghizistan 6
PE - Perù 6
TW - Taiwan 6
UA - Ucraina 6
VE - Venezuela 6
IL - Israele 5
KE - Kenya 5
SA - Arabia Saudita 5
CZ - Repubblica Ceca 4
GR - Grecia 4
MY - Malesia 4
BE - Belgio 3
GT - Guatemala 3
IR - Iran 3
PH - Filippine 3
PY - Paraguay 3
UZ - Uzbekistan 3
AL - Albania 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GY - Guiana 2
JM - Giamaica 2
JO - Giordania 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
IM - Isola di Man 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 6.309
Salva come PNG Salva come JPEG
Città #
Santa Clara 477
Singapore 412
Ashburn 280
Hong Kong 270
Hefei 238
San Jose 183
Chandler 150
Fairfield 145
Ho Chi Minh City 98
London 93
Helsinki 92
Beijing 87
Nyköping 82
Seoul 81
Milan 58
Los Angeles 51
Moscow 49
New York 48
Dallas 47
Hanoi 46
Seattle 45
Council Bluffs 44
The Dalles 44
Wilmington 44
Cambridge 41
Woodbridge 37
Houston 36
Chicago 35
Bologna 34
Shanghai 28
Jakarta 27
Lauterbourg 26
Buffalo 25
Rome 25
Princeton 23
São Paulo 23
Modena 22
San Diego 22
Salt Lake City 21
Munich 20
Nuremberg 18
Sofia 17
Ann Arbor 16
Florence 16
Kent 15
Tokyo 15
Da Nang 14
Southend 14
Atlanta 13
Haiphong 13
Rio de Janeiro 13
Orem 12
Redondo Beach 12
Reggio Emilia 12
Parma 11
Ankara 10
Portsmouth 10
Vienna 10
Biên Hòa 9
Brooklyn 9
Elk Grove Village 9
Frankfurt am Main 9
Louisville 9
Melbourne 9
Mexico City 9
Bremen 8
Casablanca 8
Des Moines 8
Ksawerów 8
Lappeenranta 8
Porto Alegre 8
Warsaw 8
Brasília 7
Columbus 7
Dearborn 7
Dublin 7
Naples 7
Padova 7
Amsterdam 6
Boardman 6
Cagliari 6
Chennai 6
Dhaka 6
Lahore 6
Paris 6
Quito 6
Santiago 6
Shijiazhuang 6
Tampa 6
Thái Bình 6
Trieste 6
Baghdad 5
Bari 5
Bishkek 5
Caivano 5
Canoas 5
Guarulhos 5
Kilburn 5
Lima 5
Lisbon 5
Totale 4.134
Salva come PNG Salva come JPEG
Nome #
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 321
VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis 302
Aortic dilatation in patients with large vessel vasculitis: A longitudinal case control study using PET/CT 268
EULAR guidelines on ANCA-associated vasculitis in the real life 264
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia 238
Association Between Specimen Length and Number of Sections and Diagnostic Yield of Temporal Artery Biopsy for Giant Cell Arteritis 224
AB0611 STRAIN ANALYSIS OF THE RIGHT VENTRICLE USING 2D-SPECKLE TRACKING ECHOCARDIOGRAPHY IN A COHORT OF PATIENTS WITH SYSTEMIC SCLEROSIS 224
Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature 192
Effectiveness and safety of a 26-week taper regimen of glucocorticoid in GCA patients: Results from a prospective cohort study 187
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 187
THU0600 a case of systemic sclerosis complicated by renal crisis: potential etiopathogenetic role of cytomegalovirus and treatment 173
Reggio Emilia (Northern Italy) Interdisciplinary Uveitis Clinic: What We Have Learned in the Last 20 Years 171
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy 170
Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: Multicenter retrospective study of 209 patients 170
Incidence and prevalence of large vessel vasculitis (giant cell arteritis and Takayasu arteritis) in northern Italy: A population-based study 168
Vessel inflammation and morphological changes in patients with large vessel vasculitis: A retrospective study 161
Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA study 160
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: A population-based study 155
Significance of inflammation restricted to adventitial/periadventitial tissue on temporal artery biopsy 151
Prevalence and distribution of vascular calcifications at CT scan in patients with and without large vessel vasculitis: A matched cross-sectional study 145
Development of the Takayasu Arteritis Integrated Disease Activity Index 142
Tocilizumab or glucocorticoids treatment for patients with SARS-CoV-2 pneumonia: An observational study 142
The management of large vessel vasculitides 140
Senescent cells in giant cell arteritis display an inflammatory phenotype participating in tissue injury via IL-6-dependent pathways 139
Failure of first anti-TNF agent in Takayasu's arteritis: to switch or to swap? 137
What to Know About Biopsy Sampling and Pathology in Vasculitis? 135
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 134
C-reactive protein gene polymorphisms influence susceptibility and outcomes of biopsy-proven giant cell arteritis in Italian patients 129
Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study 126
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis 122
The Role of PET in the Diagnosis and Disease Activity Assessment in Large Vessel Vasculitis 120
Response to: COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: A cross-sectional patient survey study' by Cuceoglu et al 118
Pros and cons of TNF inhibitors and tocilizumab in the treatment of large-vessel vasculitis 117
Response to ‘The Relevance of Restricted Inflammation in a TAB’ by Griffin KJ et al 117
Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases 115
Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospective observational study 110
Reply 109
Current management of giant cell arteritis and its complications 108
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis 76
Totale 6.367
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.730
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.730
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202167 0 0 0 0 0 0 0 0 0 18 27 22
2021/2022435 34 18 44 18 14 26 23 24 38 28 98 70
2022/2023590 54 64 33 35 71 76 31 66 82 17 32 29
2023/2024493 12 30 14 58 47 49 59 78 20 33 42 51
2024/20251.740 33 20 23 119 350 293 162 62 177 113 192 196
2025/20262.853 264 188 295 401 357 203 388 172 371 214 0 0
Totale 6.367